What is CLGN's relative strength rating?

CLGN ranks at the 28th percentile over 1 month, 14th percentile over 3 months, 9th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is CLGN in?

CLGN is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is CLGN in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CLGN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is CLGN?

CLGN currently shows a 20-day average daily range (ADR%) of 13.1%, a 90-day beta versus the S&P 500 of 1.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does CLGN have a seasonal pattern?

TickerStance computes CLGN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CLGN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did CLGN last report earnings?

No SEC EDGAR filings are linked to CLGN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) has a 3-month relative strength percentile of 14 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 30. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.1%, relative volume 2.16×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month14pctile

6 month9pctile

1 year5pctile

Classic6IBD pctile

LDR15leadership

0 of 5 lenses lit · avg RS pctile 10

✓ADR%13.1%!A/DE✓RVOL2.16×!$ Vol$22K

COMPUTED · AS OF 2026-08-24

Pattern read

CLGN is in a stage 4 downtrend, week 7. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -9.2% / -64.8%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

28

3m

14

6m

9

1y

5

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

E

RVOL todayvs 50d avg

2.16×

U/D ratiolast 50 sessions

0.90

Breakout volbreakout day vs 50d avg

+127%

50d avg $ volumeliquidity proxy

$22K

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

13.1%Elevated

ATR(14)14-day EMA

$0.04

ATR%ATR as % of close

12.04%

Beta vs SPY90d rolling

1.56

1-ADR stoprisk from close $0.30

$0.26−13.1%

Fundamentals · CLGN

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
CLGN
14RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Medical Equipment

Same industry, closest relative strength

4 peers · by RS6M

PLSMPulsenmore Ltd. Ordinary Shares9 BBLGBone Biologics Corp Common Stock9 SINTSiNtx Technologies, Inc. Common Stock10 NMTCNeuroOne Medical Technologies Corporation Common Stock10

§ Seasonality

10y · since 2022

Best monthJan on averageavg +13.48% · 75% win · n 4

Worst monthFeb on averageavg -20.14% · 25% win · n 4

CLGN monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	CLGN Jan avg: 13.48% median: 16.58% win: 75% σ: 23.11% n: 4 2022-04-12 → 2026-07-31	CLGN Feb avg: -20.14% median: -5.33% win: 25% σ: 33.41% n: 4 2022-04-12 → 2026-07-31	CLGN Mar avg: -16.07% median: -15.71% win: 25% σ: 17.71% n: 4 2022-04-12 → 2026-07-31	CLGN Apr avg: -7.52% median: -2.42% win: 40% σ: 15.47% n: 5 2022-04-12 → 2026-07-31	CLGN May avg: 11.48% median: 4.99% win: 60% σ: 23.00% n: 5 2022-04-12 → 2026-07-31	CLGN Jun avg: -18.18% median: -13.21% win: 20% σ: 23.15% n: 5 2022-04-12 → 2026-07-31	CLGN Jul avg: 3.04% median: -13.88% win: 20% σ: 42.57% n: 5 2022-04-12 → 2026-07-31	CLGN Aug avg: 9.25% median: 8.08% win: 75% σ: 10.94% n: 4 2022-04-12 → 2026-07-31 (current)	CLGN Sep avg: -7.55% median: -7.60% win: 25% σ: 8.38% n: 4 2022-04-12 → 2026-07-31	CLGN Oct avg: -14.36% median: -13.82% win: 0% σ: 10.16% n: 4 2022-04-12 → 2026-07-31	CLGN Nov avg: 1.45% median: 1.86% win: 75% σ: 16.85% n: 4 2022-04-12 → 2026-07-31	CLGN Dec avg: 6.71% median: -1.52% win: 50% σ: 45.16% n: 4 2022-04-12 → 2026-07-31

Public attention · CLGN

Is the crowd watching?

58/ 100 · vs its own 90-day norm▲ 36 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryMedical Equipment

SIC3842

Float11.0Mshares

Shares out18.9Mshares

Market cap$5.7MNano Cap

FAQ

Frequently asked questions

What is CLGN's relative strength rating?: CLGN ranks at the 28th percentile over 1 month, 14th percentile over 3 months, 9th percentile over 6 months, 5th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is CLGN in?: CLGN is classified under the Healthcare sector within the Medical Equipment industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is CLGN in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). CLGN benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is CLGN?: CLGN currently shows a 20-day average daily range (ADR%) of 13.1%, a 90-day beta versus the S&P 500 of 1.56. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does CLGN have a seasonal pattern?: TickerStance computes CLGN's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what CLGN has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did CLGN last report earnings?: No SEC EDGAR filings are linked to CLGN in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) — Stance & relative strength

CLGN is not confirmed as a leader. 14 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

CollPlant Biotechnologies Ltd Ordinary Shares (CLGN) — Stance & relative strength

CLGN is not confirmed as a leader. 14 is not yet a leadership-grade RS read, Market Stance is 47.8

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions